BCV
ACIU icon

Banque Cantonale Vaudoise’s AC Immune ACIU Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Hold
7,021
– – ﹤0.01% 209
2026
Q1 		$19K Sell
7,021
-871
-11% -$2.71K ﹤0.01% 843
2025
Q4 		$25K Sell
7,892
-10,548
-57% -$33.3K ﹤0.01% 763
2025
Q3 		$53K Hold
18,440
– – ﹤0.01% 682
2025
Q2 		$37K Sell
18,440
-8,272
-31% -$14.4K ﹤0.01% 675
2025
Q1 		$50K Buy
+26,712
New +$67.3K ﹤0.01% 683
2024
Q3 		$70K Sell
18,562
-6,856
-27% -$23.9K ﹤0.01% 589
2024
Q2 		$101K Sell
25,418
-28,716
-53% -$95K ﹤0.01% 693
2024
Q1 		$160K Sell
54,134
-713
-1% -$2.56K 0.01% 601
2023
Q4 		$274K Sell
54,847
-25,854
-32% -$83.1K 0.01% 526
2023
Q3 		$231K Hold
80,701
– – 0.01% 644
2023
Q2 		$239K Buy
80,701
+14,898
+23% +$32.5K 0.01% 674
2023
Q1 		$154K Buy
65,803
+23,315
+55% +$54K 0.01% 766
2022
Q4 		$86K Buy
42,488
+20,432
+93% +$52.7K ﹤0.01% 878
2022
Q3 		$69K Sell
22,056
-231
-1% -$728 ﹤0.01% 935
2022
Q2 		$80K Buy
22,287
+670
+3% +$2.29K ﹤0.01% 921
2022
Q1 		$86K Sell
21,617
-29,404
-58% -$127K ﹤0.01% 948
2021
Q4 		$253K Sell
51,021
-998
-2% -$5.8K 0.01% 773
2021
Q3 		$349K Sell
52,019
-19,631
-27% -$141K 0.02% 669
2021
Q2 		$568K Buy
71,650
+220
+0.3% +$1.52K 0.03% 558
2021
Q1 		$544K Buy
71,430
+13,145
+23% +$93.9K 0.03% 520
2020
Q4 		$303K Buy
58,285
+2,516
+5% +$12.8K 0.02% 634
2020
Q3 		$273K Buy
55,769
+44,455
+393% +$319K 0.02% 608
2020
Q2 		$76K Sell
11,314
-363
-3% -$2.64K 0.01% 806
2020
Q1 		$81K Sell
11,677
-286
-2% -$2.23K 0.01% 793
2019
Q4 		$102K Buy
+11,963
New +$79.7K 0.01% 806

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Banque Cantonale Vaudoise's ACIU Position: Q2 2026 in Review

Banque Cantonale Vaudoise held its AC Immune (ACIU) position steady in Q2 2026 at 7,021 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #209.

Banque Cantonale Vaudoise first reported a position in ACIU in Q4 2019 and has held it in 26 quarters since. The position peaked at $568K in Q2 2021. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Banque Cantonale Vaudoise held 7,021 shares of AC Immune worth $17K as of Q2 2026.
  • Banque Cantonale Vaudoise left its AC Immune share count unchanged in Q2 2026.
  • AC Immune made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #209 holding.
  • Banque Cantonale Vaudoise first reported a position in AC Immune in Q4 2019 and has held it in 26 quarters since.
  • Banque Cantonale Vaudoise's AC Immune position peaked at $568K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.